Neutrophil Count and Complex Lesions in Patients With Coronary Artery Disease
To the Editor:
In a recent article, Coller 1 reviews the role of leukocytosis in vascular disease morbidity and mortality. Despite the exhaustive nature of the review, we were concerned that the author failed to address an issue of major importance, namely the relationship between neutrophil count and the presence of vulnerable atheromatous plaques in patients with coronary artery disease.
Acute coronary syndromes result mainly from occlusive coronary artery thrombosis at sites of plaque fissure, rupture, or superficial erosion. At angiography, disrupted or ulcerated plaques often appear as "complex" stenoses with rough contours or "filling defects" suggestive of intracoronary thrombosis. Complex stenoses are at a higher risk of rapid progression than smooth lesions, 2 and we have recently shown that markers of both inflammation and macrophage activation predict rapid coronary artery disease progression in patients with chronic stable angina. 3 In angiographic studies in patients with chronic stable angina, we have shown that neutrophil count is an independent predictor of the presence of multiple complex stenoses irrespective of coronary artery disease extent. 4 Moreover, in patients with acute coronary syndromes, neutrophil count is also associated with coronary artery disease complexity. 5 Furthermore, neutrophil infiltration of culprit lesions with release of elastase and myeloperoxidase has been implicated in the pathogenesis of atherosclerosis. 6 These findings are important, as it has been shown that the presence of multiple complex coronary plaques is associated with adverse prognosis in patients with coronary artery disease. Neutrophil count may have also a predictive role in CSA patients in the clinical setting. New techniques such us intravascular ultrasound (IVUS) and MRI, which allow the assessment of the arterial wall and the composition of atheromatous plaques, will be instrumental in the evaluation of total atherosclerosis burden. They will represent a significant step forward in the understanding of plaque vulnerability and should help us move beyond the type of "lumenographic" analysis provided by conventional coronary angiography. 
Juan Carlos Kaski

In response:
I appreciate Drs Kaski, Avanzas, and Arroyo-Espliguero bringing to my attention their interesting studies on the association between leukocyte count, multiple complex coronary artery stenoses, and the rate of coronary disease progression. Their observations add an important dimension to the other associations that have been described between leukocytosis and vascular disease. The article that they cite by Naruko et al 1 provides histopathologic support for the presence of neutrophils in atherosclerotic lesions associated with acute coronary syndromes. In addition, since submission of my manuscript, several other studies have been published 2,3 or have come to my attention 4,5 which provide additional support for an associations of leukocytosis and cardiovascular morbidity and mortality. Thus, collectively, these data provide additional support for the association of leukocytosis and cardiovascular morbidity and mortality, and the potential direct role of leukocytes in the underlying processes of atherosclerosis and thrombosis.
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